The very acute stroke treatment: fibrinolysis and after (Q30749058)

26 June 2017

1 reference

title

The very acute stroke treatment: fibrinolysis and after (English)

1 reference

26 June 2017

Valeria Caso

1

1 reference

26 June 2017

Werner Hacke

series ordinal

2

1 reference

26 June 2017

language of work or name

1 reference

1 October 2002

1 reference

Clinical and Experimental Hypertension

26 June 2017

published in

1 reference

26 June 2017

volume

24

1 reference

26 June 2017

issue

7-8

1 reference

26 June 2017

page(s)

595-602

1 reference

Thresholds of focal cerebral ischemia in awake monkeys

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

The pathophysiology of brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: potential use in guiding thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

New Magnetic Resonance Techniques for Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

MR diffusion imaging in stroke: review and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Contrast agents in functional MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Acute stroke: usefulness of early CT findings before thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-120015335

21 January 2018

Identifiers

DOI

10.1081/CEH-120015335

1 reference

26 June 2017

1 reference